This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20170208 PLA call"
Jump to navigation
Jump to search
(One intermediate revision by the same user not shown) | |||
Line 38: | Line 38: | ||
===============================================================================---> | ===============================================================================---> | ||
|- | |- | ||
− | | || Calvin Beebe | + | |x || Calvin Beebe |
|- | |- | ||
| || Woody Beeler | | || Woody Beeler | ||
Line 50: | Line 50: | ||
| || Rick Haddorff | | || Rick Haddorff | ||
|- | |- | ||
− | | || Tony Julian | + | |x || Tony Julian |
|- | |- | ||
− | | || Paul Knapp | + | | x|| Paul Knapp |
|- | |- | ||
− | | || Austin Kreisler, | + | |x || Austin Kreisler, |
|- | |- | ||
| || Lynn Laakso | | || Lynn Laakso | ||
|- | |- | ||
− | | || Mary Kay McDaniel | + | | x|| Mary Kay McDaniel |
|- | |- | ||
− | | || Brian Pech | + | | x|| Brian Pech |
|- | |- | ||
− | | || | + | | || Wayne Kubick |
|- | |- | ||
| || John Roberts | | || John Roberts | ||
|- | |- | ||
− | | || Andy Stechishin | + | | x|| Andy Stechishin |
|- | |- | ||
Line 96: | Line 96: | ||
===Minutes=== | ===Minutes=== | ||
− | + | *Reviewed CDA MG Mission and Charter; Mary Kay displayed and made edits. | |
− | + | *Parking lot items for future MG (removed from current M&C): | |
− | + | **Review and advise on how to improve interoperability within the product family by adhering to best practices | |
+ | **Recommendations on education related to the product family | ||
+ | Manage and recommend product identity, education and intellectual property controls following precepts established by the SGB | ||
+ | *Discussion over how to select the four member representatives from across the organization. Would need to support stakeholder perspectives and domain needs. | ||
+ | *Next time: Formal relationships with other HL7 groups and with groups outside of HL7. | ||
+ | *No call 2017-02-22 or 2017-03-01 (due to HIMSS and then Harmonization)...next call 2017-03-08 | ||
===Meeting Outcomes=== | ===Meeting Outcomes=== | ||
Line 128: | Line 133: | ||
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
− | *[[ | + | *[[20170308 PLA call]] |
|} | |} | ||
© 2017 Health Level Seven® International. All rights reserved | © 2017 Health Level Seven® International. All rights reserved |
Latest revision as of 14:57, 8 March 2017
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
HL7 PLA Call Minutes Location: Phone: +1 770-657-9270, Participant Code: 985371, |
Date: 2017-02-08 Time: 2PM | ||
Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
Attendee | Name
| ||
x | Calvin Beebe | ||
Woody Beeler | |||
Lorraine Constable | |||
Bo Dagnall | |||
Jean Duteau, | |||
Rick Haddorff | |||
x | Tony Julian | ||
x | Paul Knapp | ||
x | Austin Kreisler, | ||
Lynn Laakso | |||
x | Mary Kay McDaniel | ||
x | Brian Pech | ||
Wayne Kubick | |||
John Roberts | |||
x | Andy Stechishin | ||
no quorum definition |
Agenda
Agenda review
- Notes of 20170119_PLA_WGM review
- CDAMG Mission and Charter - continue work
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
- Reviewed CDA MG Mission and Charter; Mary Kay displayed and made edits.
- Parking lot items for future MG (removed from current M&C):
- Review and advise on how to improve interoperability within the product family by adhering to best practices
- Recommendations on education related to the product family
Manage and recommend product identity, education and intellectual property controls following precepts established by the SGB
- Discussion over how to select the four member representatives from across the organization. Would need to support stakeholder perspectives and domain needs.
- Next time: Formal relationships with other HL7 groups and with groups outside of HL7.
- No call 2017-02-22 or 2017-03-01 (due to HIMSS and then Harmonization)...next call 2017-03-08
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved